Candela Stock Doubles In April As Aesthetic Lasers, Profits Attract Investors
This article was originally published in The Gray Sheet
Continued strong demand for Candela's flagship aesthetic lasers, including the GentleLase for hair removal and ScleroPlus for vascular lesions, coupled with the release of strong third-quarter financial results ahead of some analysts' expectations, drove the firm's stock price in April. The issue gained 9-3/4 points to close at 18-3/4 for the month, an increase of 108.3%.
You may also be interested in...
Continued strong interest in minimally invasive surgery by cardiac surgeons, acquisition of competitors in the sector, a new CEO and several recent product introductions appeared to help stimulate a 97.3% gain in Heartport stock in September. The issue gained 2-1/4 points to close the month at 4-9/16.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.